238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.04%
Negative revenue growth signals a shrinking top line, alarming for Benjamin Graham. Confirm if it’s cyclical or structural before proceeding.
-2.91%
Negative gross profit growth suggests either falling sales or rising direct costs. Benjamin Graham would consider this a fundamental warning sign.
-1.07%
Negative EBIT growth points to weakening core profitability. Benjamin Graham would question management efficiency.
-1.07%
Negative operating income growth means rising costs or falling revenues are eroding core profitability. Benjamin Graham would raise caution.
1.74%
Net income growth 0-5% – Barely inching up. Howard Marks would be wary of overhead or macro pressure limiting profitability gains.
No Data
No Data available this quarter, please select a different quarter.
2.63%
Diluted EPS growth 0-5% – Minimal improvement. Howard Marks would remain cautious about further dilution or flat net income.
0.19%
Share count up to +3% – Slight dilution. Howard Marks would be cautious but might accept it if used for profitable growth investments.
0.26%
Diluted share count up to +3% – Modest dilution. Howard Marks might tolerate it if used for high-ROI projects or strategic acquisitions.
No Data
No Data available this quarter, please select a different quarter.
1.43%
OCF growth 0-5% – Minimal gain. Howard Marks would be cautious about the company’s ability to fund large projects or dividends.
11.13%
FCF growth 10-15% – Solid. Seth Klarman would confirm consistency and see if the firm reinvests or returns capital effectively.
504.57%
10Y revenue/share CAGR above 15% – Exceptional long-term expansion. Warren Buffett would confirm if growth is organic, not purely from acquisitions.
118.84%
5Y CAGR above 15% – Robust mid-term revenue/share growth. Warren Buffett might ensure net margins are rising alongside top-line expansions.
56.18%
3Y CAGR above 15% – Rapid short-term revenue/share growth. Warren Buffett would see if margins are stable, ensuring profitable expansion.
600.68%
10Y OCF/share CAGR above 15% – Outstanding long-term cash-generation growth. Warren Buffett would check if reinvestment needs remain manageable.
143.29%
5Y OCF/share CAGR above 15% – Very robust mid-term cash expansion. Warren Buffett would check if reinvestment fosters sustainable growth.
111.59%
3Y OCF/share CAGR above 15% – Rapid short-term expansion. Warren Buffett would see if this stems from genuine operational improvements vs. working-capital swings.
384.58%
10Y net income/share CAGR above 15% – Exceptional long-term profit growth. Benjamin Graham would confirm if these gains hold through economic cycles.
76.72%
5Y net income/share CAGR above 15% – Strong mid-term profit growth. Benjamin Graham would check if leverage artificially boosts earnings.
52.95%
3Y net income/share CAGR above 15% – Rapid short-term profit growth. Benjamin Graham would verify if it’s driven by core revenue or temporary cost reductions.
605.92%
10Y equity/share CAGR above 12% – Excellent long-term book value compounding. Warren Buffett would see if consistent profits plus moderate payouts drive this growth.
121.08%
5Y equity/share CAGR above 12% – Strong mid-term book value expansion. Warren Buffett would see if steady profits and moderate payout ratios sustain this pace.
53.79%
3Y equity/share CAGR above 12% – Excellent recent net worth expansion. Warren Buffett would check consistent earnings retention or beneficial buybacks driving this growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.87%
Negative receivables growth can be good if demand remains stable. Benjamin Graham verifies it isn’t from a collapse in sales.
4.48%
Inventory growth 0-5% – Generally fine if revenue grows similarly. Seth Klarman confirms no shortage risk that could hamper sales.
3.14%
Asset growth 0-5% – Minimal. Howard Marks notes the firm may be optimizing existing assets or being cautious with expansions.
4.06%
2-5% annual BV/share growth – Mild. Peter Lynch sees potential if expansions or margin lifts can accelerate compounding.
0.05%
Debt rising up to 5% yoy – Mild increase. Peter Lynch sees expansions or acquisitions possibly justifying modest new debt.
8.83%
R&D growth 0-10% – Balanced approach. Seth Klarman sees manageable cost if new products are still in development.
-13.56%
Shrinking SG&A can raise profits short term, but might risk cutting key growth drivers. Benjamin Graham sees if this is sustainable.